AR 600–85 • 23 July 2020 81
(2) Measure the progress made in the ASAP prevention and risk education efforts.
(3) Measure the progress made in mandatory treatment aspects.
(4) Identify statistical trends to support requisite policy and procedural changes.
(5) Identify funding and manpower requirements for the nonclinical tenets of ASAP.
(6)
Reply to public, media, Congressional, or other Government agency inquiries.
(7) Perform background checks on ASAP military personnel. (Information will be released only to individuals who have an official need to know prior to appointing an individual into an ASAP-related position)
(8) Perform background checks on DA Civilians with prior written consent of the employee in accordance with 42
CFR dd. Information will be released only to the requesting agency designated on the consent to release form.
b. The data contained in the
DAMIS originates from the ASAP, FTDTL, SUD clinical staff, and the Army personnel database input.
c. Due to confidentiality requirements cited in paragraph 14
–
2, below,
only selected ARD, ASAP, OTSG and SUD personnel with a required need will have access to the DAMIS. See DA Pam 600
–
85 for ASAP access instructions.
d. ASAP Personnel are responsible for checking the name of individuals requiring an installation records check against the DAMIS records to identify individuals who may have had a positive drug test. This check will require the individual's consent. The background check process will consist of two separate checks, clinical and drug testing.
For the drug testing check, ASAP will provide information to the commander designated entity within 5 business days on all positive UA tests results for illegal substances and any positive test that has not been adjudicated by a MRO as authorized use, SUDCC will provide information to the commander designated entity within 5 business days on dates of screening when not enrolled with the primary basis and diagnosis if one is available and the
enrollment period if enrolled, with primary basis and diagnosis and successor failure of rehabilitation. The DA Form R will be used only for clinical information and an approved organizational form will be used for background check requests involving drug testing information.
Share with your friends: